跳至主要内容
临床试验/NCT03735251
NCT03735251已完成不适用

Epidemic Profile of Left Ventricular Diastoic Dysfunction in the Community Elderly and Establishing Prediction Model: the Northern Shanghai Study

Ya-Wei Xu0 个研究点目标入组 1,920 人开始时间: 2014年7月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,920
主要终点
left ventricular diastolic dysfunction

研究概览

简要总结

This study is one of the largest ongoing prospective population studies to evaluate target organ damages (TODs) and Left Ventricular Diastoic Dysfunction in the community-dwelling elderly Chinese, which is authorised and funded by the Shanghai municipal government.This study was approved by the Shanghai Tenth People's Hospital Institutional Review Board and was conducted under financial support from the Shanghai municipal government (grant ID: 2013ZYJB0902 and 15GWZK1002). The preliminary sample size is expected to be 3000-4000 participants.

详细描述

The Northern Shanghai Study is an ongoing prospective community-based study. After enrolment, clinical examination,anthropometric measurement and a questionnaire will be administered to each participant at baseline and patients will be followed up every six months. Our tests and examinations include: blood/urine sample and biochemical measurements, office blood pressure recording, carotid ultrasonograph, echocardiograph, pulse wave velocity, pulse wave analysis, 4-limb blood pressure recording, body mass index, etc. Baseline measurement will also include the assessments on target organ damages(TODs) and the conventional CV risk factors. In the follow-up, the incidence of CV events and mortality will be recorded. The Northern Shanghai Risk Score will be calculated, with considerations on CV risk factors and TODs.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 55 years or more
  • informed consent should be signed voluntarily
  • local residents from communities in northern Shanghai and available for long-term follow-up

排除标准

  • was diagnosed with serious heart disease (NYHA≥IV) or end-stage renal disease (CKD ≥4 stage)
  • suffered from cancer or his/her life expectancy is <5 years
  • had stroke within 3 months
  • is not willing to participate in the clinical study
  • has to quit the trial due to other diseases
  • violates the protocol or loses contact with the laboratory staff.

结局指标

主要结局

left ventricular diastolic dysfunction

时间窗: From July 2014 to August 2019

All the ultrasonography measurements are performed with a MyLab 30 CV machine (ESAOTE SpA, Genoa, Italy), according to the American Society of Echocardiography (ASE) recommendations.The echocardiography is performed in the left decubitus position. Left ventricular (LV) internal diameter at end-diastole (LVIDd) and septal (SWTd) and posterior wall thickness at end-diastole (PWTd) are measured directly. left ventricular diastolic dysfunction including: Impaired relaxation pattern:E/A\< 1,DT \> 220 ms,S/D \> 1,AR 0.21-0.28 m/sec,E/e'\<10 Pseudo-normalization pattern:E/A\> 1,DT 150\~210 ms,S/D \< 1,AR ≥0.35m/sec,E/e'≥ 10 Restrictive pattern:E/A ≥ 2,DT \< 150 ms,S/D \<1,AR ≥0.25m/sec,E/e'≥10

次要结局

未报告次要终点

研究者

发起方
Ya-Wei Xu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ya-Wei Xu

Shanghai 10th People's Hospital

Shanghai 10th People's Hospital

相似试验